BNET Industries
Last Fiscal Year Sales:$246.3M
- Public
- CA
Dow Jones Description
Developer, Mfr & Marketer of Optical Imaging Products
President & CEO
Sebastien GignacNumber of Employees 64
Peer Companies
NAICS Code Analytical Laboratory Instrument Manufacturing: 334516
Recent Events
-
Medical device company ART reaches restructuring proposal after review
-
ART Advanced Research Reveals Restructuring Agreement And Proposal To Creditors - Quick Facts
-
ART Advanced Research Technologies Launches Optix MX3 Molecular Imaging System at WMIC2009
News & Analysis
Filter by
art advanced research technologies inc. and molecular inc. - All News and Analysis
The California Nanosystems Institute at UCLA Purchases Preclinical Optical Molecular Imaging System From ART Advanced Research Technologies Inc.
ART Advanced Research Technologies Inc. ("ART") (TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce the sale of the optical molecular imaging Optix® MX2 system to the California NanoSystems Institute CNSI at UCLA, in...
The California Nanosystems Institute at UCLA Purchases Preclinical Optical Molecular Imaging System From ART Advanced Research Technologies Inc.
ART Advanced Research Technologies Inc. ("ART") (TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce the sale of the optical molecular imaging Optix® MX2 system to the California NanoSystems Institute CNSI at UCLA, in...
ART Advanced Research Technologies Molecular Imaging Platform Showcased at the World Molecular Imaging Congress in France
ART Advanced Research Technologies Inc. ("ART") (TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announced today that current research relating to its molecular imaging products will be presented at the World Molecular Imaging Congress WMIC, being held...
ART Advanced Research Technologies Secures Two Orders for its New Optix MX2 Molecular Imaging System.
MONTREAL, QUEBEC, Dec 6, 2007 Marketwire via COMTEX -- ART Advanced Research Technologies Inc. ("ART") (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce that it has received two orders for...
ART Advanced Research Technologies Inc. Presents Research Utilizing Optix and Fenestra Products at Joint Molecular Imaging Conference in Rhode Island.(Conference news)
MONTREAL, QUEBEC, Sep 7, 2007 CCNMatthews via COMTEX -- ART Advanced Research Technologies Inc. ("ART") (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announced today that it will participate in a number of presentations...
ART Advanced Research Technologies Launches a New Version of its in Vivo Optical Molecular Imaging Device for Drug Development; eXplore Optix MX2 offers new benchmark for performance and versatility.
MONTREAL, QUEBEC, May 15, 2007 CCNMatthews via COMTEX -- ART Advanced Research Technologies Inc. ("ART") (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, today announced the commercial launch of a new version of its...
Media Advisory: ART Advanced Research Technologies Launches a New Version of its in vivo Optical Molecular Imaging Device for Drug Development; eXplore Optix MX2 offers new benchmark for performance and versatility.
MONTREAL, QUEBEC, May 15, 2007 CCNMatthews via COMTEX -- ART Advanced Research Technologies Inc. ("ART") (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announced this morning the commercial launch of a new version of...
ART Advanced Research Technologies to Preview Pipeline of Molecular Imaging Products at AACR Meeting in Los Angeles
ART Advanced Research Technologies Inc. ("ART")(TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to present new developments in its molecular imaging products at the Annual Meeting of the American Association for Cancer Research AACR, being...
ART Advanced Research Technologies Presents Data From Fenestra and eXplore Optix Research at the Society for Molecular Imaging Meeting in Hawaii
ART Advanced Research Technologies Inc. ART (TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announced today that it will participate in a number of presentations relating to its eXplore Optix and Fenestra products at the fifth annual...
ART Advanced Research Technologies Presents Data From Fenestra and eXplore Optix Research at the Society for Molecular Imaging Meeting in Hawaii.
MONTREAL, CANADA, Aug 29, 2006 CCNMatthews via COMTEX -- ART Advanced Research Technologies Inc. ART (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announced today that it will participate in a number of presentations...
- 1
- 2
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Sebastien Gignac | President & CEO |
| Jacques Bedard | CFO |
| Joe Kozikowski | Chief Medical Officer |
| Warren G. Baker | COO |
| Mario Khayat | Vice President, Optical Products |
| Pierre Couture | Vice President, Sales & Marketing |
| Andreas Mirow | Marketing Manager, Product |
| Carlos Marques | General Manager, Product |
| Dr Amir H Gandjbakhche | |
| Dr Daniel B Kopans | |
| Dr David Boas | |
| Dr Irving J Bigio | |
| Dr Joseph Lakowicz | |
| Dr Martin Yaffe | |
| Jacques B E dard | |
| S E bastien Gignac | |
| Samuel Achilefu | |
| William Webb |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Benoit La Salle | Chairman |
| George N Fugelsang | Board of Directors |
| Jacques Courville | Board of Directors |
| Pierre Dutheil | Board of Directors |
| Raymond Cyr | Board of Directors |
| Rierre Dutheil | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | President & CEO | Current |
| ART Advanced Research Technologies, Inc. | Board of Directors | Current |
| ART Advanced Research Technologies, Inc. | General Counsel & Secretary | Former |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | CFO | Current |
| Organization | Position | Status |
|---|---|---|
| Clinivation, Inc. | President & CEO | Current |
| ART Advanced Research Technologies, Inc. | Chief Medical Officer | Current |
| Proformant, Inc. | Chairman and Managing Partner of Proformant | Current |
| Proformant, Inc. | CEO | Former |
| Massachusetts Gen Hospital | Principal Investigator | Former |
| Massachusetts General Hospital | Principal Investigator | Former |
| Johnson & Johnson | Former | |
| Biogen, Inc. | Former | |
| Rigid Building Systems Ltd. | Former | |
| Mallinckrodt Inc. | Former | |
| Villanova University | Former | |
| Johns Hopkins University School of Medicine | Former |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | COO | Current |
| Hewlett-Packard Company | program manager | Former |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Vice President, Optical Products | Current |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Vice President, Sales & Marketing | Current |
| Mallinckrodt Inc. | Former | |
| Tyco International Ltd. | Former | |
| McGill University | Advanced Management Course for Senior Executives | Former |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Marketing Manager, Product | Current |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | General Manager, Product | Current |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Current | |
| Harvard Medical School | Assistant Professor | Former |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Current | |
| Microsoft Corporation | Former |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Current | |
| McGill University | degrees in civil and common law | Former |
| Organization | Position | Status |
|---|---|---|
| Washington University School of Medicine | Associate Professor of Radiology | Current |
| ART Advanced Research Technologies, Inc. | Current | |
| Customized Therapeutics LLC | Current |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| SEMAFO, Inc. | President and CEO | Current |
| Pebercan Inc. | Chairman | Current |
| Afcan Mining Corp | Chairman | Current |
| ART Advanced Research Technologies, Inc. | Chairman | Current |
| LMS Medical Systems Inc. | Board of Directors | Current |
| SEMAFO, Inc. | Chairman and CEO | Former |
| LMS Medical Systems Inc. | Chairman | Current |
| Associes | Founder | Former |
| Vasogen, Inc. | Chairman | Former |
| ART Advanced Research Technologies, Inc. | Board of Directors | Former |
| Pebercan Inc. | Board of Directors | Former |
| SEMAFO, Inc. | Board of Directors | Former |
| McGill University | Masters of Business Administration from Imede, Switzerland. | Former |
| McGill University | bachelor's degree in business | Former |
| McGill University | Degree | Former |
George Fugelsang is the former Chief Executive Officer of Dresdner Kleinwort Benson North America, former Chairman of the Board of Dresdner Bank Mexico, S.A., former Chairman of the Board of Dresdner Bank Canada, and a member of the Board of Dresdner RCM Global Investors LLC. Prior to joining the Dresdner family, Mr. Fugelsang served as the Managing Director in Morgan Stanley s Investment Banking Division in London and spent more than twenty years at Citicorp/Citibank in various positions throughout the United States, Latin America, and Central, Southern, and Eastern Europe. Mr. Fugelsang serves as Deputy Chairman of the Board of Trustees of the Institute of International Bankers, and is a member of the Board of Trustees of Thunderbird (the American Graduate School of International Management) and the Board of Trustees of the Arthur F. Burns Fellowship. He is also a member of the Board of the German American Chamber of Commerce, Inc. and a Fellow of the Foreign Policy Association of New York. He graduated from the University of Oregon in 1962 with a dual major in Economics and Political Science. He continued his studies, pursuing a degree in foreign trade at the American Graduate School of International Management in Phoenix, Arizona, where he graduated with honors as the class valedictorian in 1963.
| Organization | Position | Status |
|---|---|---|
| Energy Investors Funds Group, LLC | Board of Directors | Current |
| ART Advanced Research Technologies, Inc. | Board of Directors | Current |
| Birdsong Medical Devices | Advisory Board Member | Current |
| Dresdner Kleinwort Benson | President | Former |
| Dresdner Kleinwort Benson | Chief Executive | Former |
| Morgan Stanley | Managing Director | Former |
| Dresdner Kleinwort Wasserstein | Co-Chairman | Former |
| University of Oregon | B.S. Degree In Political Science | Former |
| American Graduate School of International Management | degree in foreign trade | Former |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Board of Directors | Current |
| University of Oslo | Doctorate in Neuroanatomy | Former |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Board of Directors | Current |
| ACE Aviation Holdings Inc. | Former |
| Organization | Position | Status |
|---|---|---|
| ART Advanced Research Technologies, Inc. | Board of Directors | Current |
Executive News
-
ART Advanced Research Technologies Announces Second Quarter 2009 Financial Results Conference Call
| Volume | 2,140,470 |
| Shares Outstanding | 0. |
| Market Cap | 0. |
| Year High | 18.78 |
| Year Low | 3.87 |
| Earnings Per Share | -0.859317 |
| P/E Ratio | N/A |
| Dividend | 0.00 |
| Yield | 0.00 |
Industry Transcripts by Seeking Alpha
-
Medtronic Inc. F2Q10 (Qtr End 10/30/09) Earnings Call Transcript
on Nov 24, 2009about MDT
-
ZOLL Medical Corporation F4Q09 (Qtr End 27/09/09) Earnings Call Transcript
on Nov 11, 2009about ZOLL
-
RadNet, Inc. Q3 2009 Earnings Call Transcript
on Nov 09, 2009about RDNT
-
Cytori Therapeutics Q3 2009 Earnings Call Transcript
on Nov 09, 2009about CYTX
-
StoneMor Partners L.P. 3Q09 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 09, 2009about STON
IndustryTop Rated
- Why So Many Insured People Have Big Medical Debts 5 votes
- Healthcare Is Still Adding Jobs, Despite Recession 3 votes
- Hospital Chain's Turnaround Raises Health Spending 3 votes
- Healthcare Roundup: Medical Office Space in Demand, Blues Companies See Lower Income, Two Sides of Health Insurance, and More 3 votes
- More Insurance Competition Will Not Reduce Costs 2 votes


